New Articles

“School of Cool” Prepares Distributors to Meet Cold Chain Demands

school of cool

“School of Cool” Prepares Distributors to Meet Cold Chain Demands

With news of the COVID vaccine in the deployment phase, pharma-focused logistics processes are at the top of mind for global distributors preparing to meet demand in transporting these and other pharmaceuticals requiring temperature-controlled packaging. Pelican BioThermal’s recently launched School of Cool aims to inform, educate, and prepare its global network of distributors and customers on how to effectively prepare and utilize its temperature-controlled solutions product line.

“The events of 2020 require rapid change and innovation for businesses, as does serving a global network,” said David Williams, President of Pelican BioThermal. “School of Cool shows our continued commitment to ensuring our customers, distributors, and new employees have access to information on how to use our high-performance temperature-controlled packaging when they need it most.”

Through this on-demand and self-service style training, the leaders at Pelican BioThermal provide a four-module training process that focuses on key aspects of cold chain logistics for healthcare, pharma, biotech, and general business markets. The online learning platform currently offers four modules beginning with “What is Temperature Controlled Packaging?” and finishing with “Phase Change Material Conditioning.”

Within these four modules, distributors and customers have the opportunity to learn about the types of temperature-controlled packaging available, types of phase change materials, payload capacities, temperature ranges, and more. Pelican BioThermal confirmed additional modules are on the horizon addressing temperature ranges, parcels versus pallets, dry ice shippers, and more information on the NanoCool™ push-button cooling technology.

To register for the online training module or learn more about School of Cool, click here.

vaccine

Pelican BioThermal Announces New Offerings for COVID Vaccine Distribution

As news of the highly anticipated COVID vaccine continues to provide hope during the pandemic, Pelican BioThermal is not wasting any time preparing its temperature-controlled solutions for when the vaccine does become available and is ready for distribution.

The global temperature-controlled packaging company released information this week on newly developed deep-frozen temperature packaging solutions ideal for transporting pharma-related products requiring temperature ranges of minus 80 degrees Celsius to minus 20 degrees Celsius.

“We know that pharmaceutical companies are in all phases of the development process for vaccines and therapeutics and working tirelessly to bring safe and effective drug products to market quickly,” said Greg Wheatley, Vice President of Worldwide New Product Development and Engineering at Pelican BioThermal. “Our engineering team matched this urgency to ensure they have the correct temperature-controlled packaging to meet them where they’re at in drug development for the pandemic recovery, from discovery to distribution.”

Prior to the development and launch of the company’s new offerings, its solutions portfolio included the Crēdo™ Cube. Not only is this specific offering reusable, but it offers ranges between minus 20 degree Celsius and minus 50 degree Celsius temperatures. The company cited advances in adaption and innovation for the competitive product line now offering temperature ranges including minus 20, minus 35, minus 50, and minus 80 degrees Celsius.

The temperature-expanded product line includes the Crēdo™ Cube, CoolGuard™ Advance, CoolPal™ Flex, Sherpa Systems™, Crēdo™ Xtreme and Crēdo™ Cargo shippers along with options through the Crēdo™ on Demand rental program. Options for both single-use and reusable temperature-controlled shippers are also available.